Jane Street’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.64M Buy
+98,432
New +$2.95M ﹤0.01% 4576
2025
Q3
Sell
-360,489
Closed -$8.78M 11120
2025
Q2
$7.45M Buy
360,489
+219,655
+156% +$4.51M ﹤0.01% 2503
2025
Q1
$2.76M Sell
140,834
-122,569
-47% -$2.57M ﹤0.01% 3843
2024
Q4
$5.5M Buy
+263,403
New +$5.79M ﹤0.01% 2536
2024
Q3
Sell
-14,368
Closed -$361K 9875
2024
Q2
$361K Buy
+14,368
New +$407K ﹤0.01% 7506
2023
Q4
Sell
-18,651
Closed -$658K 9401
2023
Q3
$658K Sell
18,651
-172,462
-90% -$6.57M ﹤0.01% 5831
2023
Q2
$7.26M Sell
191,113
-13,633
-7% -$544K ﹤0.01% 2260
2023
Q1
$7.73M Buy
204,746
+190,759
+1,364% +$7.33M ﹤0.01% 1902
2022
Q4
$592K Sell
13,987
-4,617
-25% -$190K ﹤0.01% 5838
2022
Q3
$604K Buy
+18,604
New +$653K ﹤0.01% 6333
2022
Q1
Sell
-76,424
Closed -$3.08M 10555
2021
Q4
$3.08M Sell
76,424
-19,182
-20% -$800K ﹤0.01% 3638
2021
Q3
$4.18M Buy
+95,606
New +$4.29M ﹤0.01% 3034
2021
Q2
Sell
-55,672
Closed -$1.83M 9986
2021
Q1
$1.83M Buy
+55,672
New +$2.09M ﹤0.01% 4181
2020
Q4
Sell
-6,428
Closed -$233K 7707
2020
Q3
$233K Buy
+6,428
New +$232K ﹤0.01% 6239
2019
Q4
Sell
-182,955
Closed -$3.71M 5308
2019
Q3
$3.71M Buy
+182,955
New +$3.6M 0.01% 1221

Other funds holding GMAB

Jane Street's GMAB Position: Q1 2026 in Review

Jane Street opened a new position in Genmab (GMAB) in Q1 2026: 98,432 shares worth $2.64M. The stake represents ﹤0.01% of the portfolio and ranks #4576 among its holdings. This is a return to the name: Jane Street previously reported a position in GMAB as recently as Q2 2025.

Jane Street first reported a position in GMAB in Q3 2019 and has held it in 15 quarters since. The position peaked at $7.73M in Q1 2023. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Jane Street held 98,432 shares of Genmab worth $2.64M as of Q1 2026.
  • Genmab was a new Jane Street position in Q1 2026.
  • Genmab made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4576 holding.
  • Jane Street first reported a position in Genmab in Q3 2019 and has held it in 15 quarters since.
  • Jane Street's Genmab position peaked at $7.73M in Q1 2023.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.